Tag: ANDA FDA

Generic pharmaceutical companies seeking access to the United States market must submit an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA). The ANDA drug registration form and supporting documentation serve as the official regulatory submission through which a company demonstrates that its generic drug is equivalent to a previously approved…